- Home
- ASLE vs ITRM Comparison
ASLE vs ITRM Comparison
Compare ASLE & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASLE
- ITRM
- Stock Information
- Founded
- ASLE 2008
- ITRM 2015
- Country
- ASLE United States
- ITRM Ireland
- Employees
- ASLE N/A
- ITRM N/A
- Industry
- ASLE Industrial Specialties
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- ASLE Consumer Discretionary
- ITRM Health Care
- Exchange
- ASLE Nasdaq
- ITRM Nasdaq
- Market Cap
- ASLE 322.4M
- ITRM 35.6M
- IPO Year
- ASLE N/A
- ITRM 2018
- Fundamental
- Price
- ASLE $6.05
- ITRM $1.02
- Analyst Decision
- ASLE Strong Buy
- ITRM Strong Buy
- Analyst Count
- ASLE 3
- ITRM 2
- Target Price
- ASLE $8.67
- ITRM $7.00
- AVG Volume (30 Days)
- ASLE 462.3K
- ITRM 571.6K
- Earning Date
- ASLE 05-07-2025
- ITRM 05-13-2025
- Dividend Yield
- ASLE N/A
- ITRM N/A
- EPS Growth
- ASLE N/A
- ITRM N/A
- EPS
- ASLE N/A
- ITRM N/A
- Revenue
- ASLE $320,302,000.00
- ITRM N/A
- Revenue This Year
- ASLE $14.51
- ITRM N/A
- Revenue Next Year
- ASLE $18.41
- ITRM $108.39
- P/E Ratio
- ASLE N/A
- ITRM N/A
- Revenue Growth
- ASLE N/A
- ITRM N/A
- 52 Week Low
- ASLE $4.53
- ITRM $0.81
- 52 Week High
- ASLE $9.40
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- ASLE 38.46
- ITRM 44.07
- Support Level
- ASLE $5.75
- ITRM $0.88
- Resistance Level
- ASLE $7.18
- ITRM $1.14
- Average True Range (ATR)
- ASLE 0.27
- ITRM 0.10
- MACD
- ASLE -0.02
- ITRM -0.01
- Stochastic Oscillator
- ASLE 42.51
- ITRM 30.56
About ASLE AerSale Corporation
AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.